Monday, January 24, 2022, from 12:30 p.m. to 2:00 p.m. EST
With the arrival of Omicron and the looming threat of other emerging variants, one important question to be answered is: how long does immunity to SARS-CoV-2 last?
The evidence will be essential to determining Canada’s booster strategy that aims to mitigate future waves of infection, prevent undue stress on the healthcare system, and keep the population safe.
At our next Research Results & Implications seminar, COVID-19 Immunity Task Force (CITF) experts will explain the reasons behind waning antibody levels, the importance of other features of the immune system, the need for vaccine boosters, and the best dosing intervals to achieve maximum protection.
Please join us for the presentation which will be followed by a panel discussion and a question-and-answer period.